Treatment of Tetanus Symptoms
The treatment of tetanus requires immediate administration of human tetanus immunoglobulin (TIG), appropriate antibiotics (preferably metronidazole), control of muscle spasms with benzodiazepines, and intensive supportive care including possible mechanical ventilation for severe cases. 1
Initial Management
Neutralize Toxin and Eliminate Infection
Human Tetanus Immunoglobulin (TIG):
- Standard dose: 250 units intramuscularly at a site different from toxoid injection 1
- Purpose: Neutralizes circulating (unbound) toxin
- Note: Cannot reverse toxin already bound to nerve endings
Antibiotic Therapy:
- First-line: Metronidazole (preferred) 1
- Alternative: Penicillin G
- Purpose: Eliminates C. tetani to stop further toxin production
- Duration: 7-10 days
Wound Management:
Control of Muscle Spasms and Rigidity
Mild Cases:
- Benzodiazepines (diazepam) as first-line therapy 3
- Dosage: Titrate to control spasms while maintaining consciousness
- Administer in a quiet, dark room to minimize stimuli that can trigger spasms
Moderate to Severe Cases:
- Escalate to more intensive therapy based on severity
- Combination of benzodiazepines with other muscle relaxants
- Consider baclofen for additional spasticity control
Severe Cases:
Management of Complications
Respiratory Management
- Secure airway early in moderate to severe cases
- Early intubation and mechanical ventilation for:
- Laryngospasm
- Respiratory muscle rigidity
- Frequent severe spasms
- Respiratory failure
Autonomic Dysfunction Management
- Monitor for cardiovascular instability (tachycardia, hypertension, hypotension)
- Alpha and beta-blockers for sympathetic overactivity 3
- Magnesium sulfate may help control autonomic instability
- Careful fluid management to maintain hemodynamic stability
Supportive Care
- Deep vein thrombosis prophylaxis
- Pressure ulcer prevention with frequent repositioning
- Nutritional support (often requires enteral feeding)
- Prevention of nosocomial infections
- Early physiotherapy to prevent contractures and muscle atrophy 1
Special Considerations
Elderly Patients
- Neuromuscular blocking agents can have prolonged effect in elderly patients and those with renal dysfunction 1
- Higher mortality risk in patients >65 years
- May require dose adjustments for medications
Vaccination During Recovery
- Complete tetanus vaccination series during recovery period
- Active immunization with tetanus toxoid is essential as natural infection does not confer immunity 2
Prognosis and Follow-up
- Case fatality rate can reach up to 18% even with modern medical care 1
- Shorter incubation periods associated with more severe disease and poorer prognosis 1
- Recovery typically takes 4-6 weeks
- Follow-up should include:
- Neurological evaluation to identify and treat sequelae
- Personalized rehabilitation program
- Completion of tetanus vaccination series
Prevention
- Primary prevention through vaccination is the most effective strategy 2, 1
- Adults with clean minor wounds require a booster if ≥10 years since last dose 1
- For tetanus-prone wounds (contaminated, puncture, or with devitalized tissue), a booster is needed if ≥5 years since last dose 1
Remember that tetanus is a clinical diagnosis based on characteristic presentation of trismus, rigidity, and spasms. Laboratory tests are not specific for diagnosis 1. Early recognition and aggressive management are critical to improve outcomes.